Clinical Benefits of First-Line (1L) Cemiplimab Monotherapy by PD-L1 Expression Levels in Patients With Advanced NSCLC

Kilickap S., Sezer A., Gumus M., Bondarenko I., Ozguroglu M., Gogishvili M., ...More

JOURNAL OF THORACIC ONCOLOGY, vol.16, no.3, 2021 (SCI-Expanded, Scopus)

  • Publication Type: Article / Abstract
  • Volume: 16 Issue: 3
  • Publication Date: 2021
  • Journal Name: JOURNAL OF THORACIC ONCOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE
  • Hacettepe University Affiliated: Yes